Kremsmünster/Rainbach/Frickenhausen, April 4, 2016 – Greiner Bio-One, a leading international medical technology company and part of Greiner Holding AG, will in future limit its activities in the diagnostics field to the production and distribution of existing products. Greiner Bio-One Diagnostics GmbH, which is based in Rainbach im Mühlkreis, develops molecular analysis methods that enable bacteria... Read more
Lincoln, UK, 08 March 2016 – Path Links, the single managed NHS clinical pathology service operating across Lincolnshire, has upgraded to digital pathology to continue its focus on providing the highest quality diagnostic services for Northern Lincolnshire & Goole NHS Foundation Trust, United Lincolnshire Hospitals NHS Trust and 186 General Practices across the county. Path... Read more
NYON, SWITZERLAND – (January 21, 2016) – Beckman Coulter Diagnostics is pleased to announce obtaining CE Mark and the release of its new Access TSH (3rd IS) assay for use with the company’s Access Family of Immunoassay Systems. This new assay is the next generation of the Access HYPERsensitive hTSH and Access Fast hTSH... Read more
Chalfont St. Giles, UK and Toronto, Canada – 13 January 2016 – GE Healthcare, the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), and the Centre for Commercialization of Regenerative Medicine (CCRM) are building a centre for advanced therapeutic cell technologies in Toronto with an investment of CAD $40M from GE and FedDev Ontario.... Read more
Beckman Coulter Inc – Beckman Coulter, Inc. JavaScript is required for this site. Please enable JavasScript for your browser. Change Password * Indicates required fields Change Email Address * Indicates required fields Confirm Country Selection Forgot Password * Indicates required fields Forgot your password? Please provide the email address and your last name associated... Read more
California, USA – 2 October 2015 – Clarient Diagnostic Services, Inc. a division of GE Healthcare (NYSE:GE) announced it will be offering the FDA approved PD-L1 companion diagnostic which will help identify patients most likely to benefit from Merck’s newly-approved lung cancer drug, Keytruda. http://www.genewsroom.com/press-releases/precise-diagnosis-precision-lung-cancer-drug-ge-healthcare%E2%80%99s-clarient-diagnostics Read more
Access Anti-Müllerian Hormone (AMH) Assay Voted Best New Clinical Product of 2014 BREA, CALIF. – (August 31, 2015) – Beckman Coulter Diagnostics’ automated Access Anti-Müllerian Hormone (AMH) assay* was recently selected as the Best New Clinical Laboratory Product of 2014 for the 2015 Scientists’ Choice Award by members of SelectScience®. The award was presented... Read more
Dallas, Texas. – August 3, 2015 – Physicians at Southwest Diagnostic Imaging Center (SWDIC) in Dallas, Texas are now able to provide high-definition (HD) computed tomography (CT) images and lower radiation doses for a patient-focused experience thanks to the recent arrival of a new CT system. Patients in Dallas are already benefiting from the advanced... Read more
Standardized Processes and Improved Operational Efficiency Move Healthcare Forward BREA, CALIF. — (July 24, 2015) — Beckman Coulter Diagnostics will be showcasing its comprehensive portfolio of high-productivity analytical and workflow systems at the 2015 American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo in Atlanta, Ga., July 28-30, 2015. Clinical Lab... Read more
Waukesha, WI – May 20, 2015 –GE Healthcare introduced a new in-field upgrade program^ for 1.5T magnetic resonance imaging (MRI) systems in most regions globally. http://www.genewsroom.com/press-releases/field-upgrades-ge-healthcare-15t-mri-systems-signa-explorer-lift-designed-help-save Read more